Clinical course and treatment efficacy of COVID‐19 near Hubei Province, China: A multicentre, retrospective study - Zeng, Qing‐Lei; Li, Guang‐Ming; Ji, Fanpu; Ma, Shu‐Huan; Zhang, Guo‐Fan; Xu, Jiang‐Hai; Lin, Wan‐Bao; Xu, Guang‐Hua; Zhang, Guo‐Qiang; Li, Guo‐Tao; Cui, Guang‐Lin; Liu, Na; et al. (Transboundary and emerging diseases, 2020)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents - administration & dosage; anti‐viral efficacy; Child; Child, Preschool; China; Clearances; clinical course; Coronavirus disease 2019 (COVID‐19); COVID-19; COVID-19 - therapy; COVID-19 - virology; COVID-19 infection; death; disease course; epidemiology; Fatalities; Female; Fever; Health services; Henan Province; Humans; Male; Middle Aged; Neonates; Original; Patients; pneumonia; Retrospective Studies; SARS-CoV-2 - physiology; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2); Shaanxi Province; Subgroups; Viral diseases; Virus Shedding; Young Adult; China; Hubei China; anti-viral efficacy; clinical course; epidemiology; Shaanxi Province; Henan Province; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19)